MedTrace Logo

Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen

NCT01478269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1927

Last updated 2011-11-23

No results posted yet for this study

Summary

This study is a retrospective analysis of an homogeneous population of patients with aggressive B-cell lymphoma and treated upfront with R-CHOP or R-CHOP like regimens to reassess the prognostic factors and hopefully to identify more accurate prognostic subgroups with a clinical and therapeutical relevance.

Conditions

  • B-Cell Lymphomas

Sponsors & Collaborators

  • Fondazione Italiana Linfomi - ETS

    lead OTHER

Principal Investigators

  • Massimo Federico, MD · Oncologia II Azienda Ospedaliera Universitaria di Modena

  • Stefano Luminari, MD · Oncologia II Azienda Ospedaliera Universitaria di Modena

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Brazil
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01478269 on ClinicalTrials.gov